elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Peroxiredoxin
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Peroxiredoxin
RIS
0.001
(Research Intensity Score)
Papers
90
Top papers
Reactive oxygen species and cell signaling. Review
2023 · 387 citations
Mitochondria ROS and mitophagy in acute kidney injury
2022 · 788 citations
PRDX6 dictates ferroptosis sensitivity by directing cellular selenium utilization
2024 · 96 citations
PRDX6 augments selenium utilization to limit iron toxicity and ferroptosis
2024 · 106 citations
Reactive Oxygen Species: A Double-Edged Sword in the Modulation of Cancer Signaling Pathway Dynamics
2025 · 61 citations
Newest papers
Pathophysiology of reactive oxygen species (ROS)
2026 · 46 citations
The Role of Se-Containing Glutathione Peroxidases and Thioredoxin Reductases in Oncogenesis: Expression Paradoxes and Therapeutic Prospects
2026 · 10 citations
Promotion of Lead-induced Cytotoxicity in Differentiating Neural Cells and Protective Effects of Selenium
2026
Effects of cadmium stress on phenolic composition and biological activities of rosemary (Salvia rosmarinus Spenn., syn. Rosmarinus officinalis L.): LC-HRMS and in-silico insights
2026
Integrated computational and in vitro analysis reveals the toxic mechanisms of PFAS in female diminished ovarian reserve
2026
A sample from the 90 top papers behind Peroxiredoxin.
Create a free account to browse them all →
Peroxiredoxin's history
Research intensity over time
Explore Peroxiredoxin's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Peroxiredoxin's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link